Another study showing the superiority of Droperidol for agitation: adequate sedation in 15 minutes better with Droperidol (64%) than Ziprasidone (35%) or Lorazepam (29%) and lower incidence of respiratory depression with Droperidol (12%) than with Ziprasidone (36%) or Lorazepam (48%).
In a low prevalence setting (pretest probability 5%) ADD-RS >/=1 has a failure rate of 0.8% and an ADD-RS of 2 plus a normal D-dimer has a failure rate of 0.1%.
For a higher prevalence of AD (20% pretest probability), failure rate of ADD-RS alone would be 3.8%, but when adding a negative D-Dimer, the failure rate of 1 is 0.2% and 2 is 0.5%.
In summary, in a 5% pretest probability group, ADD-RS=0 rules out AD or ADD-RS=1 plus a negative D-Dimer rules out AD and in a 20% pretest probability group, an ADD-RS=0 or 1 plus a negative D-Dimer rules out AD.
HS-troponin will replace traditional older troponin assays.
This synopsis of a study in Heart showed better than 98% sensitivity for MI with a 0/1 hour protocol if pain was ❤ hours or a single troponin if pain was >3 hours.
The authors cite that a 2% miss rate may not be acceptable in the US but it is just one more study which reinforces the inevitable move toward high-sensitivity troponin.
Both pieces agree NSAIDS work well for pain, equivalent to opiates in multiple studies.
Both agree that risk of fracture healing is not significant when NSAIDS are used for first 72 hours.
Pro NSAID article argues the risk of fracture healing occurs if NSAIDS are used for>30 days, Con article says risk occurs after 3 days.
Annals explanation: “Tubercular lymphadenitis presents as a nontender, slowly progressive, unilateral swelling most commonly in the cervical region, classically named scrofula. Because of softer cartilage in children’s airways, mediastinal lymphadenitis can cause significant morbidity and even mortality owing to mass effect on the esophagus and tracheobronchial tree.”
Annals explanation: “Pott’s puffy tumor. A subperiosteal abscess with associated osteomyelitis of the frontal bone, often referred to as a Pott’s puffy tumor, is a rare entity in children. It can affect children of all ages, but most frequently affects adolescents. It is often a complication of acute bacterial rhinosinusitis, but has also been associated with trauma, surgery, drug use, mastoiditis, and dental infections. Clinical features include fever, headache, and forehead or scalp swelling and tenderness. Patients may also present with vomiting, lethargy, seizures, or altered mental status, depending on the extent of intracranial involvement. Diagnosis is clinical and radiographic, most commonly with CT, magnetic resonance imaging, or both. Management includes antimicrobials in addition to surgical drainage of the abscess, which is commonly polymicrobial with streptococcal, staphylococcal, and anaerobic organisms. The patient underwent operative drainage shortly after diagnosis and was maintained with broad-spectrum antibiotics for several days. She has since made a full recovery.”
Randomized trial where control group got usual fluid care strategy and intervention arm got a restrictive fluid strategy driven by passive leg raise and measurement of stroke volume with a noninvasive bioreactance electrode system. The restrictive fluid group had half as many patients requiring mechanical ventilation and one third as many patients requiring dialysis.
Currently many EDs don’t have the SV technology but it is a good reminder that less fluid is probably better.
Poor man’s PLR is to measure the pulse pressure (systolic bp-diastolic bp) 30-90 seconds after performing PLR. PLR done by starting patient in 45 degree upright position and then laying them flat and raising legs to 45 degrees.
Another study showing the benefit of hypertonic saline bolus to treat symptomatic hyponatremia. Unfortunately many hospitals do not allow hypertonic saline boluses, instead insisting on slow infusions of hypertonic saline not to exceed 30ml/hr, or they insist on using a central line despite studies cited by UPTODATE showing peripheral infusion is safe (Incidence of Adverse Events During Peripheral Administration of Sodium Chloride J Intensive Care Med. 2018 and Safety of Continuous Peripheral Infusion of 3% Sodium Chloride Solution in Neurocritical Care Patients Am J Crit Care. 2016).
I was able to get my hospital to agree to the 100cc hypertonic saline bolus after citing the articles and blog posts referenced here, citing that UPTODATE recommends rapid intermittent bolus therapy for severe symptomatic hyponatremia, and explaining that without the bolus option physicians are forced to use normal saline which can paradoxically lower the already low sodium concentration in SIADH patients because the saline infusion induces a diuresis of concentrated urine which (read the explanation in this UPTODATE chapter).
rather than focus on super sensitive PCR tests that are more expensive and have a slower turnaround, choose less sensitive antigen tests which cost <$5 and can be done at home or point of care with quick results.
the key is frequent testing to catch someone early in their period of transmissibility to break chain of spread.
since the trajectory of virus replication is exponential at beginning, the difference in time between when a low sensitivity and high sensitivity test become positive could be a matter of hours.
Proactively stating, “before we go on, I need to tell you something about me, I don’t do guilt,” can help ease a patient’s anxiety about answering questions of health behaviors (e.g. drugs, tobacco, alcohol, etc).
Anticoagulant Reversal Strategies in the Emergency Department Setting: Recommendations of a Multidisciplinary Expert Panel- expert guideline with significant Pharma conflicts of interest which favors expensive adexanet and idarucizumab over PCC for life threatening DOAC reversal. IBCC does not recommend Adexanet due to cost. Ultimately docs will follow their hospital protocol. Don’t forget to measure Thrombin Time which if normal negates the need for Dabigatran reversal. If no Anti-Xa assay activity, probably excludes clinically relevant levels of Xa inhibitors per 2017 ACC guideline.